Back

Rate of very late stent thrombosis differs between drug-eluting stents: a 5-year pooled landmark analysis of the SORT OUT III, IV, and V trials

27 August 2017 (17:06 - 17:15)
Organised by:
Congress Presentation Part of: Optimised myocardial revascularisation strategies PCI / stents: devices and technique ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Michael Maeng

Aarhus University Hospital, Aarhus (Denmark)

8 More presentations in this session

Presentation thumbnail
Five-year outcomes of bifurcation stenting: insights from the SYNTAX trial
Doctor M. Spaziano (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Burden and causes of rehospitalisations following coronary artery bypass grafting: a nationwide study
Mr J. Butt (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Bilateral internal mammary artery in situ versus Y-graft: mid-term results
Miss F. Saraiva (Porto, PT)
Abstract
Presentation thumbnail
Adherence to cardiac surgical waitlist guidelines is a poor predictor of cardiac surgery waitlist mortality
Doctor J. Senaratne (Edmonton, CA)
Abstract Slides Video
Presentation thumbnail
Comparative efficacy and safety of novel biodegradable polymer sirolimus-eluting stents versus permanent polymer everolimus-eluting stents at 5-year follow-up
Doctor R. Colleran (Dublin 7, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Optimised myocardial revascularisation strategies

The Event

Event poster

ESC Congress 2017

27 August 2017 17:06 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources